Zyx 3 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

zyx 3 mg

viatris as - benzydaminhydroklorid - sugetablett med eukalyptussmak - 3 mg

Zyx 3 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

zyx 3 mg

viatris as - benzydaminhydroklorid - sugetablett med honning/appelsinsmak - 3 mg

Zyx 3 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

zyx 3 mg

viatris as - benzydaminhydroklorid - sugetablett med mintsmak - 3 mg

Zyx 3 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

zyx 3 mg

viatris as - benzydaminhydroklorid - sugetablett med sitronsmak - 3 mg

Mykofenolsyre Accord 180 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

mykofenolsyre accord 180 mg

accord healthcare b.v. - mykofenolatnatrium - enterotablett - 180 mg

Mykofenolsyre Accord 360 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

mykofenolsyre accord 360 mg

accord healthcare b.v. - mykofenolatnatrium - enterotablett - 360 mg

Sunitinib Accord यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Enteroporc Coli AC यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

enteroporc coli ac

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - griser - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Sunitinib Sandoz 12.5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

sunitinib sandoz 12.5 mg

sandoz - københavn - sunitinib - kapsel, hard - 12.5 mg

Sunitinib Sandoz 25 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

sunitinib sandoz 25 mg

sandoz - københavn - sunitinib - kapsel, hard - 25 mg